On February 15, Yifan Pharmaceuticals announced that its holding subsidiary, Yifan Yosemite, had recently received a notice from its shareholders and the entrusted pharmaceutical manufacturer Jutai Pharmaceuticals that Yifan Yosemite had all the rights to inject the products under development.
With cefuroxime sodium, it has been reviewed by the National Center for Drug Evaluation and passed the consistency evaluation of generic drugs
.
Cefuroxime sodium for injection is a second-generation cephalosporin antibiotic, mainly used for infections caused by sensitive bacteria, including respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, sepsis, meningitis, gonorrhea, Bone and joint infections, puerperium and gynecological infections
.
According to the data from Minet.
com, the sales of cefuroxime sodium for injection in China in 2019 and 2020 were 5.
227 billion yuan and 4.
375 billion yuan respectively
.
